In addition, a higher relapse rate was observed in patients with MICA-129 met as compared to those with MICA-129 val/val genotype because of reduced graft versus leukemia effect of NK and CD8+ cells consequent to downregulation of NKG2D by MICA-129 met variants. This evidence concerns the gene MICA and leukemia.